CTX321
LIVE

Serial Number

99583004

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

Filing Date

Jan 7, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CTX321 Trademark

Serial Number: 99583004

CTX321 is a trademark filed by CRISPR Therapeutics AG on January 7, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

January 7, 2026

Registration Date

Not Registered

Published for Opposition

June 9, 2026

Goods & Services

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy

Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 11, 2026 CNSA
ASSIGNED TO EXAMINER
May 6, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 7, 2026 MAFR
NEW APPLICATION ENTERED
Jan 7, 2026 NWAP